Trial · NCT04567628
Results by group11
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 11 of 11
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| TDM Cohort: Correlation Between Week 6 Vedolizumab TDM and Week 30 Faecal Calprotectin (FCP) | TDM Cohort | -0.23 | correlation coefficient | ||
| TDM Cohort: C-reactive Protein (CRP) Level at Week 30 | TDM Cohort: Ulcerative Colitis | 2 | Inter-Quartile Range 1 to 5 | mg/L | |
| TDM Cohort: C-reactive Protein (CRP) Level at Week 30 | TDM Cohort: Crohn's Disease | 3 | Inter-Quartile Range 1 to 6 | mg/L | |
| TDM Cohort: Disease Score for Crohn's Disease (CD) Participants Based on Harvey-Bradshaw Index (HBI) at Week 30 | TDM Cohort: Crohn's Disease | 3 | Inter-Quartile Range 1 to 6 | score on a scale | |
| TDM Cohort: Disease Score for Ulcerative Colitis (UC) Participants Based on Partial Mayo Score at Week 30 | TDM Cohort: Ulcerative Colitis | 1 | Inter-Quartile Range 0 to 3 | score on a scale | |
| Number of Participants Categorized Based on Dose Escalation | TDM Cohort | 173 | Participants | ||
| Number of Participants Categorized Based on Dose Escalation | Historical Cohort | 852 | Participants | ||
| TDM Cohort: Number of Participants Categorized Based on Treatment Persistence at the End of the TDM Study at Week 30 | TDM Cohort | Treatment Persistence | 360 | Participants | |
| TDM Cohort: Number of Participants Categorized Based on Treatment Persistence at the End of the TDM Study at Week 30 | TDM Cohort | Did not Persist on Treatment | 76 | Participants | |
| Treatment Duration | TDM Cohort | 378.0 | Inter-Quartile Range 238.0 to 553.5 | days | |
| Treatment Duration | Historical Cohort | 242.0 | Inter-Quartile Range 116.0 to 437.5 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04567628/results